Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria is a research paper published in Frontiers in Genetics (2022). On theSindex it has a DataRank of 0.434. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI NIH HHS
Grant: U01 HL156942
National Institutes of Health
Grant: 1U24HL135881-01
The Sickle Pan-African Research Consortium (SPARCO)
National Institutes of Health
Grant: 5U01HL156942-05
Sickle Pan African Research Consortium Nigeria (SPARC-NEt)
FWCI
2.04
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals